BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23168082)

  • 1. Synthesis, characterization and antimalarial activity of quinoline-pyrimidine hybrids.
    Pretorius SI; Breytenbach WJ; de Kock C; Smith PJ; N'Da DD
    Bioorg Med Chem; 2013 Jan; 21(1):269-77. PubMed ID: 23168082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds.
    Rojas Ruiz FA; García-Sánchez RN; Estupiñan SV; Gómez-Barrio A; Torres Amado DF; Pérez-Solórzano BM; Nogal-Ruiz JJ; Martínez-Fernández AR; Kouznetsov VV
    Bioorg Med Chem; 2011 Aug; 19(15):4562-73. PubMed ID: 21723734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antiplasmodial activity and mechanistic studies of pyrimidine-5-carbonitrile and quinoline hybrids.
    Kaur H; Balzarini J; de Kock C; Smith PJ; Chibale K; Singh K
    Eur J Med Chem; 2015 Aug; 101():52-62. PubMed ID: 26114811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives.
    Barteselli A; Parapini S; Basilico N; Mommo D; Sparatore A
    Bioorg Med Chem; 2014 Nov; 22(21):5757-65. PubMed ID: 25311562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antimalarial activity of a series of bisquinoline and bispyrrolo[1,2a]quinoxaline compounds.
    van Heerden L; Cloete TT; Breytenbach JW; de Kock C; Smith PJ; Breytenbach JC; N'Da DD
    Eur J Med Chem; 2012 Sep; 55():335-45. PubMed ID: 22889556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors.
    Kayamba F; Malimabe T; Ademola IK; Pooe OJ; Kushwaha ND; Mahlalela M; van Zyl RL; Gordon M; Mudau PT; Zininga T; Shonhai A; Nyamori VO; Karpoormath R
    Eur J Med Chem; 2021 May; 217():113330. PubMed ID: 33744688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives.
    Whittell LR; Batty KT; Wong RP; Bolitho EM; Fox SA; Davis TM; Murray PE
    Bioorg Med Chem; 2011 Dec; 19(24):7519-25. PubMed ID: 22055713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
    Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization and antimalarial activity of new chromium arene-quinoline half sandwich complexes.
    Glans L; Taylor D; de Kock C; Smith PJ; Haukka M; Moss JR; Nordlander E
    J Inorg Biochem; 2011 Jul; 105(7):985-90. PubMed ID: 21565148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Piperonyl substitution on aminoquinoline-pyrimidine hybrids: Effect on the antiplasmodial potency.
    Kholiya R; Khan SI; Bahuguna A; Tripathi M; Rawat DS
    Eur J Med Chem; 2017 May; 131():126-140. PubMed ID: 28315598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline.
    Delarue-Cochin S; Grellier P; Maes L; Mouray E; Sergheraert C; Melnyk P
    Eur J Med Chem; 2008 Oct; 43(10):2045-55. PubMed ID: 18226428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
    Zishiri VK; Joshi MC; Hunter R; Chibale K; Smith PJ; Summers RL; Martin RE; Egan TJ
    J Med Chem; 2011 Oct; 54(19):6956-68. PubMed ID: 21875063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin.
    Guetzoyan L; Yu XM; Ramiandrasoa F; Pethe S; Rogier C; Pradines B; Cresteil T; Perrée-Fauvet M; Mahy JP
    Bioorg Med Chem; 2009 Dec; 17(23):8032-9. PubMed ID: 19879150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiplasmodial evaluation of novel (4-aminobutyloxy)quinolines.
    Vandekerckhove S; Müller C; Vogt D; Lategan C; Smith PJ; Chibale K; De Kimpe N; D'hooghe M
    Bioorg Med Chem Lett; 2013 Jan; 23(1):318-22. PubMed ID: 23195733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies.
    Singh K; Kaur H; Smith P; de Kock C; Chibale K; Balzarini J
    J Med Chem; 2014 Jan; 57(2):435-48. PubMed ID: 24354322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.
    Ryckebusch A; Deprez-Poulain R; Maes L; Debreu-Fontaine MA; Mouray E; Grellier P; Sergheraert C
    J Med Chem; 2003 Feb; 46(4):542-57. PubMed ID: 12570376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity.
    Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):481-4. PubMed ID: 19054674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.
    Kumar A; Srivastava K; Kumar SR; Siddiqi MI; Puri SK; Sexana JK; Chauhan PM
    Eur J Med Chem; 2011 Feb; 46(2):676-90. PubMed ID: 21194812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.
    Boechat N; Ferreira Mde L; Pinheiro LC; Jesus AM; Leite MM; Júnior CC; Aguiar AC; de Andrade IM; Krettli AU
    Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.